Literature DB >> 11172000

A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.

L Li1, J Liao, J Ruland, T W Mak, S N Cohen.   

Abstract

The p53 tumor suppressor protein and the MDM2 oncoprotein form a feedback-control loop that up-regulates cellular MDM2 production, blocks p53 activity, and promotes p53 decay. tsg101 was discovered as a gene whose deficiency results in neoplastic transformation of NIH 3T3 cells and the ability to generate metastatic tumors in nude mice. Its protein product contains a domain, Ubc, characteristic of the catalytic domain of ubiquitin conjugase (E2) enzymes but lacking an active-site cysteine crucial for ubiquitin conjugase activity. Here we report that TSG101 participates with MDM2 in an autoregulatory loop that modulates the cellular levels of both proteins, and also of p53, by affecting protein decay. We show that the Ubc domain of TSG101 interferes with ubiquitination of MDM2, that TSG101 inhibits MDM2 decay and elevates its steady-state level, and that these events are associated with down-regulation of p53 protein. Conversely, pulse-chase and Western blot experiments in wild-type and mutant fibroblasts indicate that elevation of MDM2 by overexpression of wild-type p53, by amplification of the endogenous MDM2 gene, or by transfection of MDM2-expressing constructs promotes TSG101 loss, which we show occurs by 26S proteasome-dependent decay. Our results identify TSG101 as both a regulator of, and target of, MDM2/p53 circuitry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172000      PMCID: PMC29306          DOI: 10.1073/pnas.98.4.1619

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins.

Authors:  A B Hittelman; D Burakov; J A Iñiguez-Lluhí; L P Freedman; M J Garabedian
Journal:  EMBO J       Date:  1999-10-01       Impact factor: 11.598

Review 2.  The ARF/p53 pathway.

Authors:  C J Sherr; J D Weber
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

Review 3.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

4.  Biochemistry. All in the ubiquitin family.

Authors:  M Hochstrasser
Journal:  Science       Date:  2000-07-28       Impact factor: 47.728

5.  SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

Authors:  T Buschmann; S Y Fuchs; C G Lee; Z Q Pan; Z Ronai
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

6.  Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.

Authors:  D C Olson; V Marechal; J Momand; J Chen; C Romocki; A J Levine
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

7.  Mapping of the p53 and mdm-2 interaction domains.

Authors:  J Chen; V Marechal; A J Levine
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence.

Authors:  G H Feng; C J Lih; S N Cohen
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

9.  p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101.

Authors:  J Ruland; C Sirard; A Elia; D MacPherson; A Wakeham; L Li; J L de la Pompa; S N Cohen; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

10.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

View more
  58 in total

1.  Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

Authors:  Stijn Heessen; Ainars Leonchiks; Natalia Issaeva; Anatoly Sharipo; Galina Selivanova; Maria G Masucci; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 2.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies.

Authors:  Mar Perez; Rebecca C Craven; Juan C de la Torre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-16       Impact factor: 11.205

Review 4.  Defective downregulation of receptor tyrosine kinases in cancer.

Authors:  Kristi G Bache; Thomas Slagsvold; Harald Stenmark
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

Review 5.  Tied up in loops: positive and negative autoregulation of p53.

Authors:  Xin Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

6.  The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.

Authors:  Gisselle Medina; Yongjun Zhang; Yi Tang; Eva Gottwein; Marcy L Vana; Fadila Bouamr; Jonathan Leis; Carol A Carter
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

Review 7.  Biogenesis and function of multivesicular bodies.

Authors:  Robert C Piper; David J Katzmann
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

8.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 9.  Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Authors:  Beata Pyrzynska; Iwona Pilecka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

10.  Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death.

Authors:  Andrea Krempler; MaLinda D Henry; Aleata A Triplett; Kay-Uwe Wagner
Journal:  J Biol Chem       Date:  2002-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.